COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Relationship between cultural food taboos and maternal and child nutrition: A systematic literature review
- Quality Evaluation and Storage Stability of Low-Fat Chin-Chin Formulated with Wheat-Soybean Residue (Okara) Flour Blends
- Effect of healthy lifestyle promotion on anthropometric variables, eating behavior and cardiometabolic risk factors in women with polycystic ovarian syndrome
- Adherence to the Mediterranean Diet and anthropometric profile of obese Algerian subjects
- Epidemiology, diagnosis, and assessment of diabetes mellitus in the elderly population: a purposive review
- Glutamine and sickle cell disease in Brazilian scenario
- Enhancing food security through scientific research in Algeria. A novel vision and unified national strategy
- Overview of Food Safety and Labeling Regulatory Frameworks in Morocco
- Polyvinyl Alcohol Films with Algerian Eruca vesicaria Extract as Natural Antioxidants for Food Packaging
- The Impact of Outdoor Grazing on Launaea taraxacifolia on the Nutritional Profile, Fatty Acid Composition, and Sensory Attributes of Goliath Chicken Meat in Benin
You may also start an advanced similarity search for this article.
NAJFNR is licensed under